Committed to delivering
innovation for patients.
Scientific Advisory Board
MD, PhD, HDR
Curie Institute (France)
Professor Bonvalot is a surgeon with nearly 20 years of experience in specialized surgery of sarcoma and complex tumors. She currently serves as the Head of Sarcoma Surgery at the Institut Curie in Paris, France. Prior to that, she worked as head of digestive surgery at Gustave Roussy in Villejuif, France for over 20 years.
Lausanne University Hospital (Switzerland)
Dr. Bourhis is a radiation oncologist with a clinical focus on head and neck oncology. He currently serves as Professor and Chief of Radiation Oncology at the Lausanne University Hospital in Lausanne, Switzerland. Prior to that he was Chairman of the Radiation Oncology Department at the Institute Gustave Roussy in Villejuif, France.
MD, MS, PhD
Gustave Roussy (France)
Dr. Champiat is a medical oncologist with a particular interest in the development of novel immunotherapies including intra-tumoral treatment strategies. Currently he is an Assistant Professor at the Drug Development Department of Gustave Roussy Cancer Campus in Paris, France where he heads the inpatient unit. Prior to that he was an assistant Professor at Paris-Saclay University in Paris.
Thierry De Baère
Gustave Roussy (France)
Dr. De Baère is an interventional radiologist with over 20 years of experience exploring minimal invasive therapies for the treatment of liver, lung, and kidney tumors. He currently serves as Head of the Interventional Radiology Unit at Gustave Roussy Cancer Centre in Villejuif, France, and is Professor of Medicine at the University Paris-Saclay in Paris, France.
Robert L. Ferris
MD, PhD, FACS
University of Pittsburgh Medical Center (US)
Dr. Ferris is a surgeon who brings over 20 years of experience as a head and neck surgical oncologist and translational tumor immunologist. He currently serves as a Professor of Oncology and Director of the UPMC Hillman Cancer Center. He is also Associate Vice Chancellor for Cancer Research, and Professor of Otolaryngology, of Immunology, and of Radiation Oncology at the University of Pittsburgh.
Silvia Chiara Formenti
New York-Presbyterian-Weill-Cornell Medical Center (US)
Dr. Formenti is a medical and radiation oncologist specializing in the systemic effects of radiotherapy on the immune system. She currently serves as Chairman of the Department of Radiation Oncology at Weill Cornell in New York, and Associate Director of the Meyer Cancer Center and Radiation Oncologist in Chief at NewYork-Presbyterian Hospital.
Quynh-Thu Xuan Le
Stanford University (US)
Dr. Le is a radiation oncologist that brings expertise in head and neck cancers, specifically leading clinical trials testing novel radiosensitizers or radioprotectors in combination with chemoradiotherapy. She currently serves as the Chair of the Stanford Radiation Oncology Department and holds the Katharine Dexter McCormick & Stanley Memorial Professorship at Stanford University in Palo Alto, California.
Nancy Y. Lee
Memorail Sloan Kettering Cancer Center (US)
Dr. Lee brings 17 years of experience as a radiation oncologist and specializes in advanced forms of radiation to treat head and neck cancer. She currently serves as the Vice Chair of the Department of Radiation Oncology, Service Chief of Head & Neck Radiation Oncology and Service Chief of Proton Therapy at Memorial Sloan Kettering Cancer Center in New York, New York.
Christophe Le Tourneau
Curie Institute (France)
Dr. Le Tourneau is a medical oncologist specializing in phase I clinical trials, precision medicine approaches, and head and neck oncology. He currently serves in Paris, France as a Senior Medical Oncologist at the Institut Curie and as Professor of Medicine at the Paris-Saclay University where he heads the Department of Drug Development and Innovation (D3i) and the Head and Neck Cancer Clinic.
PhD, BMedSc, MBChB, FRCS, FRCS
University Hospital Birmingham (UK)
Dr. Mehanna is a surgeon who specializes in head and neck cancer. He is the Deputy Pro-Vice Chancellor, Chair of Head and Neck Surgery, and Director of the Institute of Head and Neck Studies and Education at the University of Birmingham in the United Kingdom.
Chiaojung Jillian Tsai
Princess Margaret Cancer Center (Canada)
She previously was the Director of Metastatic Disease Radiation Oncology Clinical Research at Memorial Sloan Kettering Cancer Center in New York, and recently joined the Radiation Medicine Program at Princess Margaret Cancer Centre in Toronto, where she will lead the Palliative Radiation Oncology Program.
Jared Marc Weiss
University of North Carolina (US)
Dr. Weiss is a medical oncologist specializing in immunotherapies for head and neck cancer and lung cancer. Currently he is a Professor of Medicine-Oncology at the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, where he also serves as Section Chief of Thoracic and Head and Neck Oncology.